PTLA Insider Trading Activity and SEC Form 4 Filings
PTLA insider trading summary
No open-market insider purchases or sales of Portola Pharmaceuticals Inc (PTLA) have been reported on SEC Form 4 in the past 12 months.
Latest PTLA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 1, 2019 | Hollings Renton | Director | Sell | $150K (5,000 @ $30.00) |
| Aug 8, 2019 | Hollings Renton | Director | Sell | $150K (5,000 @ $30.00) |
| Apr 15, 2019 | Hollings Renton | Director | Sell | $158K (4,600 @ $34.40) |
| Apr 15, 2019 | Hollings Renton | Director | Sell | $14K (400 @ $35.07) |
| Apr 4, 2019 | Mardi Dier | EVP, CFO & Cbo | Sell | $1.5M (40,486 @ $37.39) |
| Dec 17, 2018 | Charles J Homcy | Director | Sell | $13K (700 @ $19.20) |
| Dec 17, 2018 | Charles J Homcy | Director | Sell | $1.2M (63,518 @ $18.60) |
| Aug 23, 2018 | Jeffrey W Bird | Director | Buy | $1.3M (50,355 @ $26.65) |
| Aug 22, 2018 | Jeffrey W Bird | Director | Buy | $5.3M (202,082 @ $26.09) |
| Aug 21, 2018 | Jeffrey W Bird | Director | Buy | $3.5M (137,563 @ $25.17) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.